EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $519,568 | -6.2% | 18,314 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $553,733 | +107421.0% | 18,944 | -2.8% | 0.00% | 0.0% |
| Q3 2022 | $515 | -99.9% | 19,481 | -5.8% | 0.00% | -50.0% |
| Q2 2022 | $919,000 | -12.7% | 20,687 | -2.7% | 0.01% | +33.3% |
| Q1 2022 | $1,053,000 | -10.7% | 21,271 | -8.1% | 0.01% | 0.0% |
| Q4 2021 | $1,179,000 | -9.2% | 23,151 | -0.6% | 0.01% | -14.3% |
| Q3 2021 | $1,299,000 | +17.0% | 23,291 | -10.2% | 0.01% | 0.0% |
| Q2 2021 | $1,110,000 | -9.8% | 25,923 | -12.1% | 0.01% | -12.5% |
| Q1 2021 | $1,231,000 | +3.0% | 29,498 | +15.0% | 0.01% | -11.1% |
| Q4 2020 | $1,195,000 | +4.9% | 25,661 | -4.3% | 0.01% | 0.0% |
| Q3 2020 | $1,139,000 | +4.9% | 26,811 | +18.5% | 0.01% | -10.0% |
| Q2 2020 | $1,086,000 | +4.3% | 22,631 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $1,041,000 | -23.5% | 22,631 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $1,360,000 | -6.2% | 22,631 | -11.7% | 0.01% | -20.0% |
| Q3 2019 | $1,450,000 | +14.8% | 25,631 | +13.0% | 0.01% | 0.0% |
| Q2 2019 | $1,263,000 | +155.7% | 22,691 | +131.8% | 0.01% | +150.0% |
| Q1 2019 | $494,000 | +25.4% | 9,791 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $394,000 | -26.1% | 9,791 | +27.3% | 0.00% | -25.0% |
| Q3 2018 | $533,000 | +37.7% | 7,691 | +50.3% | 0.00% | +33.3% |
| Q2 2018 | $387,000 | +43.3% | 5,118 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $270,000 | -1.1% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $273,000 | -10.5% | 5,118 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $305,000 | -7.9% | 5,118 | +21.9% | 0.00% | -66.7% |
| Q2 2017 | $331,000 | -28.7% | 4,200 | -25.0% | 0.00% | -25.0% |
| Q1 2017 | $464,000 | +4.5% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $444,000 | +13.3% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $392,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |